These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 30824357

  • 1. Identification of domains within Pfs230 that elicit transmission blocking antibody responses.
    Tachibana M, Miura K, Takashima E, Morita M, Nagaoka H, Zhou L, Long CA, Richter King C, Torii M, Tsuboi T, Ishino T.
    Vaccine; 2019 Mar 22; 37(13):1799-1806. PubMed ID: 30824357
    [Abstract] [Full Text] [Related]

  • 2. Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.
    Miura K, Takashima E, Deng B, Tullo G, Diouf A, Moretz SE, Nikolaeva D, Diakite M, Fairhurst RM, Fay MP, Long CA, Tsuboi T.
    Infect Immun; 2013 Dec 22; 81(12):4377-82. PubMed ID: 24042109
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential ability of specific regions of Plasmodium falciparum sexual-stage antigen, Pfs230, to induce malaria transmission-blocking immunity.
    Bustamante PJ, Woodruff DC, Oh J, Keister DB, Muratova O, Williamson KC.
    Parasite Immunol; 2000 Aug 22; 22(8):373-80. PubMed ID: 10972844
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunogenicity of malaria transmission-blocking vaccine candidate, y230.CA14 following crosslinking in the presence of tetanus toxoid.
    Vincent AA, Fanning S, Caira FC, Williamson KC.
    Parasite Immunol; 1999 Nov 22; 21(11):573-81. PubMed ID: 10583858
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity.
    Tachibana M, Wu Y, Iriko H, Muratova O, MacDonald NJ, Sattabongkot J, Takeo S, Otsuki H, Torii M, Tsuboi T.
    Clin Vaccine Immunol; 2011 Aug 22; 18(8):1343-50. PubMed ID: 21715579
    [Abstract] [Full Text] [Related]

  • 10. Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230.
    Healer J, McGuinness D, Carter R, Riley E.
    Parasitology; 1999 Nov 22; 119 ( Pt 5)():425-33. PubMed ID: 10599074
    [Abstract] [Full Text] [Related]

  • 11. Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice.
    Healy SA, Anderson C, Swihart BJ, Mwakingwe A, Gabriel EE, Decederfelt H, Hobbs CV, Rausch KM, Zhu D, Muratova O, Herrera R, Scaria PV, MacDonald NJ, Lambert LE, Zaidi I, Coelho CH, Renn JP, Wu Y, Narum DL, Duffy PE.
    J Clin Invest; 2021 Apr 01; 131(7):. PubMed ID: 33561016
    [Abstract] [Full Text] [Related]

  • 12. Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum.
    Kapulu MC, Da DF, Miura K, Li Y, Blagborough AM, Churcher TS, Nikolaeva D, Williams AR, Goodman AL, Sangare I, Turner AV, Cottingham MG, Nicosia A, Straschil U, Tsuboi T, Gilbert SC, Long CA, Sinden RE, Draper SJ, Hill AV, Cohuet A, Biswas S.
    Sci Rep; 2015 Jun 11; 5():11193. PubMed ID: 26063320
    [Abstract] [Full Text] [Related]

  • 13. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T, Komesu A, Otsuki H, Sattabongkot J, Udomsangpetch R, Matsumoto Y, Tsuji N, Wu Y, Torii M, Tsuboi T.
    Infect Immun; 2005 Nov 11; 73(11):7375-80. PubMed ID: 16239536
    [Abstract] [Full Text] [Related]

  • 14. Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins.
    Singh K, Burkhardt M, Nakuchima S, Herrera R, Muratova O, Gittis AG, Kelnhofer E, Reiter K, Smelkinson M, Veltri D, Swihart BJ, Shimp R, Nguyen V, Zhang B, MacDonald NJ, Duffy PE, Garboczi DN, Narum DL.
    Commun Biol; 2020 Jul 24; 3(1):395. PubMed ID: 32709983
    [Abstract] [Full Text] [Related]

  • 15. Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes.
    Williamson KC, Keister DB, Muratova O, Kaslow DC.
    Mol Biochem Parasitol; 1995 Dec 24; 75(1):33-42. PubMed ID: 8720173
    [Abstract] [Full Text] [Related]

  • 16. Pfs230: from malaria transmission-blocking vaccine candidate toward function.
    Williamson KC.
    Parasite Immunol; 2003 Jul 24; 25(7):351-9. PubMed ID: 14521577
    [No Abstract] [Full Text] [Related]

  • 17. Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230.
    Riley EM, Williamson KC, Greenwood BM, Kaslow DC.
    Parasite Immunol; 1995 Jan 24; 17(1):11-9. PubMed ID: 7731731
    [Abstract] [Full Text] [Related]

  • 18. Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding.
    Kumar R, Angov E, Kumar N.
    Infect Immun; 2014 Apr 24; 82(4):1453-9. PubMed ID: 24421036
    [Abstract] [Full Text] [Related]

  • 19. A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system.
    Lee SM, Hickey JM, Miura K, Joshi SB, Volkin DB, King CR, Plieskatt JL.
    Sci Rep; 2020 Jan 15; 10(1):395. PubMed ID: 31942034
    [Abstract] [Full Text] [Related]

  • 20. Functional Characterization and Comparison of Plasmodium falciparum Proteins as Targets of Transmission-blocking Antibodies.
    Nikolaeva D, Illingworth JJ, Miura K, Alanine DGW, Brian IJ, Li Y, Fyfe AJ, Da DF, Cohuet A, Long CA, Draper SJ, Biswas S.
    Mol Cell Proteomics; 2020 Jan 15; 19(1):155-166. PubMed ID: 29089373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.